Selected research
Industry Research
Customized Peptide Synthesis Service Industry Research Report 2026
Market perspective
The global Customized Peptide Synthesis Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Customized Peptide Synthesis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Customized Peptide Synthesis Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Customized Peptide Synthesis Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Customized Peptide Synthesis Service include Nissan Chemical, BACHEM, Evonik, WATANABE CHEMICAL INDUSTRIES, LTD., VARSAL, Advanced ChemTech, CPC Scientific, Thermo Scientific and Pepscan, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Customized Peptide Synthesis Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Customized Peptide Synthesis Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Customized Peptide Synthesis Service Market by Company
Nissan Chemical
BACHEM
Evonik
WATANABE CHEMICAL INDUSTRIES, LTD.
VARSAL
Advanced ChemTech
CPC Scientific
Thermo Scientific
Pepscan
JPT Peptide Technologies
Abclonal
Biocompare
Biosynth
Aurigene
RS Synthesis
CHINESE PEPTIDE
WuXi TIDES
Abclonal
Make Research Easy
anhuabio
GL Biochem (Shanghai) Ltd
Customized Peptide Synthesis Service Segment by Type
Small Batch
Large Batch
Customized Peptide Synthesis Service Segment by Application
Research
Pharmaceutical
Customized Peptide Synthesis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Customized Peptide Synthesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Customized Peptide Synthesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Customized Peptide Synthesis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Customized Peptide Synthesis Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Small Batch
- Large Batch
Applications
- Research
- Pharmaceutical
Companies covered
- Nissan Chemical
- BACHEM
- Evonik
- WATANABE CHEMICAL INDUSTRIES, LTD.
- VARSAL
- Advanced ChemTech
- CPC Scientific
- Thermo Scientific
- Pepscan
- JPT Peptide Technologies
- Abclonal
- Biocompare
- Biosynth
- Aurigene
- RS Synthesis
- CHINESE PEPTIDE
- WuXi TIDES
- Abclonal
- Make Research Easy
- anhuabio
- GL Biochem (Shanghai) Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Customized Peptide Synthesis Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Small Batch
- 2.2.3 Large Batch
- 2.3 Customized Peptide Synthesis Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Research
- 2.3.3 Pharmaceutical
- 2.4 Assumptions and Limitations
3 Customized Peptide Synthesis Service Breakdown Data by Type
- 3.1 Global Customized Peptide Synthesis Service Historic Market Size by Type (2021-2026)
- 3.2 Global Customized Peptide Synthesis Service Forecasted Market Size by Type (2027-2032)
4 Customized Peptide Synthesis Service Breakdown Data by Application
- 4.1 Global Customized Peptide Synthesis Service Historic Market Size by Application (2021-2026)
- 4.2 Global Customized Peptide Synthesis Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Customized Peptide Synthesis Service Market Perspective (2021-2032)
- 5.2 Global Customized Peptide Synthesis Service Growth Trends by Region
- 5.2.1 Global Customized Peptide Synthesis Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Customized Peptide Synthesis Service Historic Market Size by Region (2021-2026)
- 5.2.3 Customized Peptide Synthesis Service Forecasted Market Size by Region (2027-2032)
- 5.3 Customized Peptide Synthesis Service Market Dynamics
- 5.3.1 Customized Peptide Synthesis Service Industry Trends
- 5.3.2 Customized Peptide Synthesis Service Market Drivers
- 5.3.3 Customized Peptide Synthesis Service Market Challenges
- 5.3.4 Customized Peptide Synthesis Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Customized Peptide Synthesis Service Players by Revenue
- 6.1.1 Global Top Customized Peptide Synthesis Service Players by Revenue (2021-2026)
- 6.1.2 Global Customized Peptide Synthesis Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Customized Peptide Synthesis Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Customized Peptide Synthesis Service Head Office and Area Served
- 6.4 Global Customized Peptide Synthesis Service Players, Product Type & Application
- 6.5 Global Customized Peptide Synthesis Service Manufacturers Established Date
- 6.6 Global Customized Peptide Synthesis Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Customized Peptide Synthesis Service Market Size (2021-2032)
- 7.2 North America Customized Peptide Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Customized Peptide Synthesis Service Market Size by Country (2021-2026)
- 7.4 North America Customized Peptide Synthesis Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Customized Peptide Synthesis Service Market Size (2021-2032)
- 8.2 Europe Customized Peptide Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Customized Peptide Synthesis Service Market Size by Country (2021-2026)
- 8.4 Europe Customized Peptide Synthesis Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Customized Peptide Synthesis Service Market Size (2021-2032)
- 9.2 Asia-Pacific Customized Peptide Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Customized Peptide Synthesis Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Customized Peptide Synthesis Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Customized Peptide Synthesis Service Market Size (2021-2032)
- 10.2 South America Customized Peptide Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Customized Peptide Synthesis Service Market Size by Country (2021-2026)
- 10.4 South America Customized Peptide Synthesis Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Customized Peptide Synthesis Service Market Size (2021-2032)
- 11.2 Middle East & Africa Customized Peptide Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Customized Peptide Synthesis Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Customized Peptide Synthesis Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Nissan Chemical
- 12.1.1 Nissan Chemical Company Information
- 12.1.2 Nissan Chemical Business Overview
- 12.1.3 Nissan Chemical Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.1.4 Nissan Chemical Customized Peptide Synthesis Service Product Portfolio
- 12.1.5 Nissan Chemical Recent Developments
- 12.2 BACHEM
- 12.2.1 BACHEM Company Information
- 12.2.2 BACHEM Business Overview
- 12.2.3 BACHEM Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.2.4 BACHEM Customized Peptide Synthesis Service Product Portfolio
- 12.2.5 BACHEM Recent Developments
- 12.3 Evonik
- 12.3.1 Evonik Company Information
- 12.3.2 Evonik Business Overview
- 12.3.3 Evonik Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.3.4 Evonik Customized Peptide Synthesis Service Product Portfolio
- 12.3.5 Evonik Recent Developments
- 12.4 WATANABE CHEMICAL INDUSTRIES, LTD.
- 12.4.1 WATANABE CHEMICAL INDUSTRIES, LTD. Company Information
- 12.4.2 WATANABE CHEMICAL INDUSTRIES, LTD. Business Overview
- 12.4.3 WATANABE CHEMICAL INDUSTRIES, LTD. Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.4.4 WATANABE CHEMICAL INDUSTRIES, LTD. Customized Peptide Synthesis Service Product Portfolio
- 12.4.5 WATANABE CHEMICAL INDUSTRIES, LTD. Recent Developments
- 12.5 VARSAL
- 12.5.1 VARSAL Company Information
- 12.5.2 VARSAL Business Overview
- 12.5.3 VARSAL Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.5.4 VARSAL Customized Peptide Synthesis Service Product Portfolio
- 12.5.5 VARSAL Recent Developments
- 12.6 Advanced ChemTech
- 12.6.1 Advanced ChemTech Company Information
- 12.6.2 Advanced ChemTech Business Overview
- 12.6.3 Advanced ChemTech Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.6.4 Advanced ChemTech Customized Peptide Synthesis Service Product Portfolio
- 12.6.5 Advanced ChemTech Recent Developments
- 12.7 CPC Scientific
- 12.7.1 CPC Scientific Company Information
- 12.7.2 CPC Scientific Business Overview
- 12.7.3 CPC Scientific Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.7.4 CPC Scientific Customized Peptide Synthesis Service Product Portfolio
- 12.7.5 CPC Scientific Recent Developments
- 12.8 Thermo Scientific
- 12.8.1 Thermo Scientific Company Information
- 12.8.2 Thermo Scientific Business Overview
- 12.8.3 Thermo Scientific Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.8.4 Thermo Scientific Customized Peptide Synthesis Service Product Portfolio
- 12.8.5 Thermo Scientific Recent Developments
- 12.9 Pepscan
- 12.9.1 Pepscan Company Information
- 12.9.2 Pepscan Business Overview
- 12.9.3 Pepscan Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.9.4 Pepscan Customized Peptide Synthesis Service Product Portfolio
- 12.9.5 Pepscan Recent Developments
- 12.10 JPT Peptide Technologies
- 12.10.1 JPT Peptide Technologies Company Information
- 12.10.2 JPT Peptide Technologies Business Overview
- 12.10.3 JPT Peptide Technologies Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.10.4 JPT Peptide Technologies Customized Peptide Synthesis Service Product Portfolio
- 12.10.5 JPT Peptide Technologies Recent Developments
- 12.11 Abclonal
- 12.11.1 Abclonal Company Information
- 12.11.2 Abclonal Business Overview
- 12.11.3 Abclonal Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.11.4 Abclonal Customized Peptide Synthesis Service Product Portfolio
- 12.11.5 Abclonal Recent Developments
- 12.12 Biocompare
- 12.12.1 Biocompare Company Information
- 12.12.2 Biocompare Business Overview
- 12.12.3 Biocompare Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.12.4 Biocompare Customized Peptide Synthesis Service Product Portfolio
- 12.12.5 Biocompare Recent Developments
- 12.13 Biosynth
- 12.13.1 Biosynth Company Information
- 12.13.2 Biosynth Business Overview
- 12.13.3 Biosynth Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.13.4 Biosynth Customized Peptide Synthesis Service Product Portfolio
- 12.13.5 Biosynth Recent Developments
- 12.14 Aurigene
- 12.14.1 Aurigene Company Information
- 12.14.2 Aurigene Business Overview
- 12.14.3 Aurigene Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.14.4 Aurigene Customized Peptide Synthesis Service Product Portfolio
- 12.14.5 Aurigene Recent Developments
- 12.15 RS Synthesis
- 12.15.1 RS Synthesis Company Information
- 12.15.2 RS Synthesis Business Overview
- 12.15.3 RS Synthesis Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.15.4 RS Synthesis Customized Peptide Synthesis Service Product Portfolio
- 12.15.5 RS Synthesis Recent Developments
- 12.16 CHINESE PEPTIDE
- 12.16.1 CHINESE PEPTIDE Company Information
- 12.16.2 CHINESE PEPTIDE Business Overview
- 12.16.3 CHINESE PEPTIDE Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.16.4 CHINESE PEPTIDE Customized Peptide Synthesis Service Product Portfolio
- 12.16.5 CHINESE PEPTIDE Recent Developments
- 12.17 WuXi TIDES
- 12.17.1 WuXi TIDES Company Information
- 12.17.2 WuXi TIDES Business Overview
- 12.17.3 WuXi TIDES Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.17.4 WuXi TIDES Customized Peptide Synthesis Service Product Portfolio
- 12.17.5 WuXi TIDES Recent Developments
- 12.18 Abclonal
- 12.18.1 Abclonal Company Information
- 12.18.2 Abclonal Business Overview
- 12.18.3 Abclonal Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.18.4 Abclonal Customized Peptide Synthesis Service Product Portfolio
- 12.18.5 Abclonal Recent Developments
- 12.19 Make Research Easy
- 12.19.1 Make Research Easy Company Information
- 12.19.2 Make Research Easy Business Overview
- 12.19.3 Make Research Easy Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.19.4 Make Research Easy Customized Peptide Synthesis Service Product Portfolio
- 12.19.5 Make Research Easy Recent Developments
- 12.20 anhuabio
- 12.20.1 anhuabio Company Information
- 12.20.2 anhuabio Business Overview
- 12.20.3 anhuabio Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.20.4 anhuabio Customized Peptide Synthesis Service Product Portfolio
- 12.20.5 anhuabio Recent Developments
- 12.21 GL Biochem (Shanghai) Ltd
- 12.21.1 GL Biochem (Shanghai) Ltd Company Information
- 12.21.2 GL Biochem (Shanghai) Ltd Business Overview
- 12.21.3 GL Biochem (Shanghai) Ltd Revenue in Customized Peptide Synthesis Service Business (2021-2026)
- 12.21.4 GL Biochem (Shanghai) Ltd Customized Peptide Synthesis Service Product Portfolio
- 12.21.5 GL Biochem (Shanghai) Ltd Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst